CAITLIN KOTZ: Open Payments
NPI 1043963754 · CHESTER, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$711 in 36 payments from 10 companies in 2025. Trend: 2023 $109 · 2024 $441 · 2025 $711
Food & beverage: $711
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 17 | $262 |
| Braeburn Inc. | 2 | $139 |
| Merck Sharp & Dohme LLC | 4 | $80 |
| Novo Nordisk Inc | 4 | $71 |
| Indivior Inc. | 3 | $51 |
| PFIZER INC. | 2 | $36 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Alkermes, Inc. | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
Products named: MINIMED 780G, BRIXADI, SUBLOCADE, Ozempic, TRUMENBA, Rybelsus, CAPVAXIVE, PROQUAD.
Industry payments across NJ — which companies pay providers there.
